Last reviewed · How we verify
BZL101
At a glance
| Generic name | BZL101 |
|---|---|
| Sponsor | Bionovo |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer (PHASE1, PHASE2)
- A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BZL101 CI brief — competitive landscape report
- BZL101 updates RSS · CI watch RSS
- Bionovo portfolio CI